Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.
Press releases published on May 30, 2025

Global Wearable Robot Technology Market Forecast: Key Growth Drivers, Trends, And Opportunities From 2025 To 2034
The Business Research Company's Wearable Robot Technology Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 30, 2025 /EINPresswire.com/ -- What Is The Forecasted Growth Of The …

Global Western Blotting Market Insights 2025: Key Trends, Market Size, and Growth Forecast
The Business Research Company's Western Blotting Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 30, 2025 /EINPresswire.com/ -- What Is The Expected Growth Rate And Size Of The …

Sepsis Diagnostics Market Analysis: Key Trends, Share, Growth Drivers, And Forecast 2025-2034
The Business Research Company's Sepsis Diagnostics Market Analysis: Key Trends, Share, Growth Drivers, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 30, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report …

Global Vitreoretinal Disorder Market: Key Drivers, Trends, Growth Opportunities & Forecast 2025–2034 – Insights
The Business Research Company's Vitreoretinal Disorder Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 30, 2025 /EINPresswire.com/ -- What Is The Forecasted Growth Of The …

Global Walking Assist Devices Market Forecast: Key Growth Drivers, Trends, And Opportunities From 2025 To 2034
The Business Research Company's Walking Assist Devices Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 30, 2025 /EINPresswire.com/ -- In recent years, the walking assist devices …

Workplace Wellness Market Forecast 2025-2034: Insights on Size, Growth, Trends & Competitive Landscape
The Business Research Company’s Workplace Wellness Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 30, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report …

TravelingWiki's Jonathan Sutter Cited w/United Airlines, Airbus & Emirates as Leading Challenge to Existing Travel Norms
TravelingWiki CEO Jonathan Sutter has been named as the leading compelling antithetical to the status quo in Autism …

Prothrombin Complex Concentrate Global Market Report 2025: Powerful Industry Growth Overview
The Business Research Company's Prothrombin Complex Concentrate Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 30, 2025 /EINPresswire.com/ -- The Business Research Company’s …

Wiskott-Aldrich Syndrome Treatment Market Report 2025: Size, Trends, and Growth Insights for Global Expansion
The Business Research Company’s Wiskott-Aldrich Syndrome Treatment Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 30, 2025 /EINPresswire.com/ -- The Business Research Company’s …

Global Proteus Syndrome Market Insights 2025: Key Trends, Market Size, and Growth Forecast
The Business Research Company's Proteus Syndrome Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 30, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report …

Celularity Receives Nasdaq Notice Regarding Form 10-Q
FLORHAM PARK, N.J., May 30, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a cellular and regenerative medicine company, today announced that on May 28, 2025, Nasdaq notified the Company that it did not timely file …

COSCIENS Biopharma Inc. Reconstitutes Board for Benefit of Shareholders
Reconstituted Board to Revitalize COSCIENS TORONTO, May 30, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI; TSX: CSCI) today announced that it has entered into a resolution agreement (the “Resolution Agreement”) with Goodwood Inc., Goodwood …

The London Clinic is the first independent hospital to offer GALEAS™ bladder cancer tests
May is Bladder Cancer Awareness Month and this test, which is supported by charity Action Bladder Cancer, could reduce suffering for thousands of patients. BIRMINGHAM, WEST MIDLANDS, UNITED KINGDOM, May 30, 2025 /EINPresswire.com/ -- Nonacus Clinical …

Microbial pioneers: how bacteria shape dental implant health from day one
GA, UNITED STATES, May 30, 2025 /EINPresswire.com/ -- A new study suggests that the earliest microbes to colonize a dental implant may determine its long-term fate. Using high-resolution genomic sequencing and a 12-week clinical timeline, scientists …

Fate Therapeutics Appoints Matthew Abernethy, M.B.A., to its Board of Directors
SAN DIEGO, May 30, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a pipeline of induced pluripotent stem cell (iPSC)-derived off-the-shelf cellular immunotherapies to …

Publication relating to transparency notifications
REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), May 30, 2025, 10:30 pm CET / 4:30 pm ET – In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large …

Publication relative à des notifications de transparence
INFORMATION RÉGLEMENTÉE Publication relative à des notifications de transparence Mont-Saint-Guibert (Belgique), le 30 mai 2025, 22:30h CET / 16:30h ET – Conformément à l'article 14 de la loi du 2 mai 2007 relative à la publicité des participations …

Plus Therapeutics Reports First Quarter Financial Results and Recent Business Highlights
Company continues to progress both REYOBIQ™ radiotherapeutic clinical trials and CNSide® CSF assay platform launch readiness HOUSTON, May 30, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a clinical-stage …

NurExone Announces Clinical Trial Plans for Acute Spinal Cord Injury Therapy at Annual Meeting of American Spinal Injury Association
TORONTO and HAIFA, Israel, May 30, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) is pleased to announce that Professor Nahshon Knoller M.D., senior clinical advisor to the Company, will …

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
VANCOUVER, British Columbia and BOSTON, May 30, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for …